We're a Rare Breed Find out why.
Capabilities It's what we do.
- Strategic Consulting
- Creative Services
- Technology
- Research & Analytics
Join Our Mailing List
All fields required. We respect your privacy and
do not provide information to third parties.
Engaging Solutions for all audiences.
What's the Latest from around the industry.
UK first EU nation to launch flutiform k-haler for asthma
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler... Read more
AstraZeneca, Amgen’s tezepelumab wins 'breakthrough' status
AstraZeneca and Amgen’s tezepelumab has won breakthrough therapy status in the US... Read more
MS Society launches petition against rejection of Ocrevus
The MS Society has launched a petition imploring the National Institute for Health and Care Excellence... Read more
